Therapeutic peptides: current applications and future directions
L Wang, N Wang, W Zhang, X Cheng, Z Yan… - Signal transduction and …, 2022 - nature.com
Peptide drug development has made great progress in the last decade thanks to new
production, modification, and analytic technologies. Peptides have been produced and …
production, modification, and analytic technologies. Peptides have been produced and …
Cyclic peptides for drug development
Cyclic peptides are fascinating molecules abundantly found in nature and exploited as
molecular format for drug development as well as other applications, ranging from research …
molecular format for drug development as well as other applications, ranging from research …
Unusual amino acids in medicinal chemistry
MAT Blaskovich - Journal of medicinal chemistry, 2016 - ACS Publications
Unusual amino acids are fundamental building blocks of modern medicinal chemistry. The
combination of readily functionalized amine and carboxyl groups attached to a chiral central …
combination of readily functionalized amine and carboxyl groups attached to a chiral central …
Targeting transcription factors for cancer treatment
M Lambert, S Jambon, S Depauw… - Molecules, 2018 - mdpi.com
Transcription factors are involved in a large number of human diseases such as cancers for
which they account for about 20% of all oncogenes identified so far. For long time, with the …
which they account for about 20% of all oncogenes identified so far. For long time, with the …
Rational design of peptide-based inhibitors disrupting protein-protein interactions
X Wang, D Ni, Y Liu, S Lu - Frontiers in chemistry, 2021 - frontiersin.org
Protein-protein interactions (PPIs) are well-established as a class of promising drug targets
for their implications in a wide range of biological processes. However, drug development …
for their implications in a wide range of biological processes. However, drug development …
Cyclic peptides as drugs for intracellular targets: the next frontier in peptide therapeutic development
LK Buckton, MN Rahimi… - Chemistry–A European …, 2021 - Wiley Online Library
Develo** macrocyclic peptides that can reach intracellular targets is a significant
challenge. This review discusses the most recent strategies used to develop cell permeable …
challenge. This review discusses the most recent strategies used to develop cell permeable …
Self-assembling peptide-based building blocks in medical applications
Peptides and peptide-conjugates, comprising natural and synthetic building blocks, are an
increasingly popular class of biomaterials. Self-assembled nanostructures based on …
increasingly popular class of biomaterials. Self-assembled nanostructures based on …
[PDF][PDF] The first-in-class peptide binder to the SARS-CoV-2 spike protein
The first-in-class peptide binder to the SARS-CoV-2 spike protein Authors: G. Zhang1, S.
Pomplun1, AR Loftis1, A. Loas1, and Page 1 1 1 2 3 4 The first-in-class peptide binder to the …
Pomplun1, AR Loftis1, A. Loas1, and Page 1 1 1 2 3 4 The first-in-class peptide binder to the …
Pharmacological inhibition of LSD1 for cancer treatment
GJ Yang, PM Lei, SY Wong, DL Ma, CH Leung - Molecules, 2018 - mdpi.com
Lysine-specific demethylase 1A (LSD1, also named KDM1A) is a demethylase that can
remove methyl groups from histones H3K4me1/2 and H3K9me1/2. It is aberrantly expressed …
remove methyl groups from histones H3K4me1/2 and H3K9me1/2. It is aberrantly expressed …
Investigation of ACE2 N-terminal fragments binding to SARS-CoV-2 Spike RBD
Abstract Coronavirus disease 19 (COVID-19) is an emerging global health crisis. With over 7
million confirmed cases to date, this pandemic continues to expand, spurring research to …
million confirmed cases to date, this pandemic continues to expand, spurring research to …